Hims & Hers Halts Weight-Loss Pill After FDA Legal Threat

Hims & Hers Health halted the sale of its cheaper weight-loss pill following legal threats from Novo Nordisk and a promised crackdown by the Food and Drug Administration.Commissioner Marty Makary warned of potential DOJ referrals and ingredient restrictions after the telehealth company launched the $49 monthly treatment as an alternative to Wegovy.The withdrawal follows a significant drop in Novo Nordisk stock value and warnings from pharmaceutical leaders regarding the safety of unapproved medications.